Investor FAQs


Novus is headquartered at 19900 MacArthur Blvd., Suite 550, Irvine, CA 92612. The main phone number is (949) 238-8090.

The company was originally incorporated in the state of Delaware under the name Tokai Pharmaceuticals, Inc. in 2004 and subsequently changed its name to Novus Therapeutics, Inc. in 2017.

Novus is traded on the NASDAQ Capital Market under the ticker symbol NVUS and its CUSIP number is 67011N 105.

Shares of NVUS can be purchased through a stockbroker of your choice.

December 31st

Continental Stock Transfer & Trust
Phone: (212) 845-3224
17 Battery Place, 8th Floor
New York, NY 10004
www.continentalstock.com/contact/

Press release archives can be accessed in the Press Releases section of the website.

SEC filings can be accessed in the SEC Filings section of the site or www.sec.gov.

You may submit your questions to Investor Relations by contacting investors@novustherapeutics.com